While oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen (CMRO 2 ) are fundamental parameters of brain health and function, a robust MRI-based mapping of OEF and CMRO 2 amenable to functional MRI (fMRI) has not been established. To address this issue, a novel method called QUantitative Imaging of eXtraction of Oxygen and TIssue Consumption, or QUIXOTIC, is introduced. The key innovation in QUIXOTIC is the use of velocity-selective spin labeling to isolate MR signal exclusively from postcapillary venular blood on a voxel-by-voxel basis. Measuring the T 2 of this venular-targeted blood allows calibration to venular oxygen saturation (Y v ) via theoretical and experimental T 2 versus blood oxygen saturation relationships. Y v is converted to OEF, and baseline CMRO 2 is subsequently estimated from OEF and additional cerebral blood flow and hematocrit measurements. Theory behind the QUIXOTIC technique is presented, and implications of cutoff velocity (V CUTOFF ) and outflow time parameters are discussed. Cortical gray matter values obtained with QUIXOTIC in 10 healthy volunteers are Y v = 0.73 ± 0.02, OEF = 0.26 ± 0.02, and CMRO 2 = 125 ± 15 μmol/100 g min. Results are compared to global measures obtained with the T 2 relaxation under spin tagging (TRUST) technique. The preliminary data presented suggest that QUIXOTIC will be useful for mapping Y v , OEF, and CMRO 2 , in both clinical and functional MRI settings.
consumption to oxygen delivery is called the oxygen extraction fraction (OEF). OEF can be expressed in terms of CMRO 2 and CBF (2, 3) in the following manner: [1] where [Hb total ] is the total concentration of hemoglobin in blood and Y a is the arterial oxygen saturation.
One of the main difficulties in measuring OEF and CMRO 2 with in vivo 1 H MRI is the lack of a direct contrast mechanism. However, as hemoglobin modulates MR signal relaxivity based on degree of oxygen saturation (Y), the possibility to indirectly assess OEF and CMRO 2 arises. Venous oxygen saturation (Y v ) is extrapolated from the MRI signal and used first to compute OEF (3): [2] where arteriolar blood is assumed fully saturated (Y a = 1) or measured independently by pulse oximetry. Following Eq. 1, CMRO 2 is then calculated from OEF and additional CBF and hematocrit measurements. As oxygen is typically extracted as blood traverses the capillary network, Y v measurements focused at the distal end of the network (i.e., in postcapillary venules) will yield spatially specific OEF and CMRO 2 estimates.
One class of methods to measure Y v uses phase contrast imaging to examine magnetic susceptibility differences between veins and surrounding tissue (4-7) and uses simple, firstprinciple models to relate phase changes to Y v . These methods have the advantage of straightforward acquisitions via standard MRI sequences, but require manually visualizing vessels, limiting use in measuring regional or voxelwise Y v . A second class of methods (8, 9) invokes an MRI signal model that quantifies Y v based on dHb-induced signal loss in extravascular tissue. One such approach developed by An et al. uses a single compartment tissue model to produce OEF (8) and CMRO 2 (10) maps. He and Yablonskiy (9) have introduced "quantitative BOLD" which considers a multiple-compartment model and accounts for tissue, blood, and cerebrospinal fluid (CSF) signal and similarly produces OEF maps. This latter approach is especially promising and has been recently used in assessing change in OEF during functional stimulation (11) .
A third class of methods to measure Y v implements an intravascular T 2 -based approach and has shown promise in functional MRI (fMRI) settings. This approach uses a theoretically and empirically derived relationship between blood transverse (T 2 ) relaxation time and blood oxygen saturation (Y) (2) . Specifically measuring Y v requires selective targeting of blood in the venous circulation, without partial voluming with tissue, CSF, or other brain constituents. Isolating this pure venous blood signal, however, has been a major challenge for existing techniques.
As a consequence, intravascular methods require strict selection criteria to identify voxels containing exclusively venous blood. Methods presented by Oja et al. (3) and Golay et al. (12) , for example, require functional activation experiments to identify candidate voxels, and of these, only a subset can be used to calculate Y v . Moreover, because of resolution limitations, usable voxels are typically found only in larger venous vessels. As blood oxygenation in these larger vessels represents oxygen exchange of all supplying capillaries in a large surrounding region, these techniques have fundamental limitations on spatial specificity. Voxelwise Y v is unfortunately not feasible.
More recently, Lu and Ge have proposed T 2 relaxation under spin tagging (TRUST) MRI and measure Y v in the sagittal sinus (13) . TRUST-MRI delivers a pure blood signal, free from partial volume effects, by using a spin-labeling approach to eliminate static tissue and CSF via control-tag subtraction. While TRUST is an important advance for T 2 -based, Y v methodology, only global estimates are possible, as blood signal is isolated from the largest cerebral veins (i.e., the sagittal sinus). As such, TRUST Y v measurements are limited to the terminal draining veins; regional Y v information is consequently lost.
Our work uses the intravascular T 2 -based approach but addresses the largest obstacle for localized measurements: the isolation of postcapillary venular (PCV) blood signal. A novel excitation scheme is proposed that uses velocity-selective spin labeling (VSSL) to isolate PCV blood signal. In principle, the methodology uses velocity-sensitive pulses to exploit heterogeneous blood velocities in the vascular tree and subsequently create a flowdependent venular blood component that persists after control-tag subtraction. This sequence incorporates T 2 preparation-based technology, acquires PCV blood-weighted images at effective echo times, and exponentially fits these data to estimate PCV blood T 2 . T 2,blood versus Y curves (with hematocrit as an independent parameter) are then generated from theoretical models and existing 3 T data and are used to calibrate PCV blood T 2 
THEORY

Venular-Targeted Velocity-Selective Spin Labeling
The key innovation behind the QUIXOTIC approach is venular-targeted VSSL (VT-VSSL). VT-VSSL allows targeting of MR signal exclusively from the PCV blood compartment, from which T 2 and Y v can be measured. VT-VSSL applies velocity-sensitive MR pulses to exploit differential velocities and accelerations of blood in the vascular tree, and relies on uniformly forward flow from arteries, through capillaries, to veins. The two-step data acquisition paradigm creates control and tag images with and without the desired venular blood component, respectively. Subsequent pairwise control-tag subtraction eliminates signal from static tissue, CSF, and nonvenular blood compartments, leaving an image exclusively containing blood in the postcapillary venules. The following section describes the details and timing behind this approach.
QUIXOTIC is adapted from velocity-selective (VS) arterial spin labeling (14) and uses similar VS modules to dephase blood spins above a given cutoff velocity. The pulse sequence is summarized schematically in Fig. 1 and executed for both tag and control acquisitions.
The principal component of the QUIXOTIC excitation scheme is the VS module. As a time derivative of position, velocity can be phase encoded by applying bipolar gradient pulses, or equivalently, unipolar pulses separated by a 180° refocusing pulse (15) . Inserting this phase-encoding scheme between two excitation pulses with opposite phase (90° − 90°̅ ) results in the following radiofrequency (RF) pulse train: 90° − G − 180° − G − 90°̅ . When applied to laminar flow systems found in noncapillary vasculature of the human circulatory system, the result is a filtering of the magnetization from moving blood spins flowing below a certain cutoff velocity (V CUTOFF ) and elimination of magnetization from spins flowing above V CUTOFF , according to: [3] where M 0 is the initial magnetization, v is spin velocity. β is related to the separation (Δ), duration (δ), and amplitude (G) of the bipolar gradient pulses in the following manner: [4] where γ is the gyromagnetic ratio for protons. The first zero-crossing thus defines V CUTOFF (14, 16) : [5] Figure 2 displays the sinc-filter profile and the ideal velocity filter for comparison.
Instead of using a 90° − G − 180° − G − 90°̅ pulse train, which can be implemented with simple hard RF pulses, a four RF and four gradient approach was used (as suggested in Ref.
14): [6] which incorporates adiabatic pulses as the refocusing 180°s. This train offers greater resistance to transmitted field (B 1 + ) and static field (B 0 ) inhomogeneity, water diffusion, and eddy current effects (14, 17) . Prior investigations using this eight-pulse sequence (14) verify its superior performance with reduced artifacts compared to data acquired with the simpler 90° − G − 180° − G − 90°̅ train (16) . The final VS train is shown in Fig. 3 ; for perfect spinecho refocusing, the adiabatic refocusing pulses are symmetrically spaced.
The difference between the QUIXOTIC tag and control acquisitions lies in the second VS module. While the tag acquisition applies a user-defined cutoff velocity (V CUTOFF ) for both VS module I (VS1) and VS module II (VS2), the control uses V CUTOFF for VS1, but disables velocity selection for VS2 (i.e., flowing spins are unaffected, V CUTOFF = infinity). Incorporated into VS2 is a T 2 -preparation module (18, 19) , allowing T 2 estimation via data acquisition at multiple echo times. An important feature of the sequence is an inversion pulse at TO 1 , which compensates for adverse effects of T 1 relaxation that could potentially introduce unwanted signal from arterial blood.
To introduce properties of this sequence, we first neglect T 1 relaxation and the TO 1 inversion pulse. Figure 4 provides an idealized cartoon depicting blood spins in the circulation for both control and tag acquisitions, their history during the pulse sequence timing, and the final contribution in the subtracted image. At t = 0, before VS1, all blood (arterial, venous, capillary) is relaxed (Fig. 4a) . Strong velocity weighting (low V CUTOFF ) is then applied during VS1 for both tag and control, selecting for slow moving spins in small arterioles, capillaries, and small venules (V < V CUTOFF ) but dephasing faster moving spins in larger vessels (V > V CUTOFF ) (resulting in a loss of signal, Fig. 4b) . Notably, this largevessel signal is eliminated on both sides of the circulation. After VS1, the outflow time (TO) allows the targeted blood to flow out of the small vessel compartments and accelerate into larger venular vasculature (Fig. 4c) . VS2 is then applied at TO. This time, however, the tag and control acquisition experience different velocity weighting: the tag sees velocity selection at V CUTOFF , but the control experiences no velocity weighting. Spins that have accelerated above V CUTOFF during TO are dephased by the tag acquisition but left unaltered in the control (Fig. 4d) . As imaging starts immediately after VS2, subtraction of tag from control yields an image weighted to blood that has accelerated from below V CUTOFF to above V CUTOFF , during TO (Fig. 4e) . Assuming flow always progresses from arteries to capillaries to veins, these spins are venous only. Signal from other sources (static, CSF, nonvenular blood) is eliminated via subtraction. If V CUTOFF and TO are chosen properly, signal from PCV blood is exclusively targeted.
Due to the tortuous nature of human vasculature, the spatial direction of flow naturally varies as blood migrates from arteries to capillaries to veins. This phenomenon, however, is not expected to appreciably affect the venular selectivity of the VT-VSSL experiment for the following reasons: first, as phase encoding does not occur during TO (the longest interval of the experiment), the directional changes during this interval have no impact on velocity selection. Conversely, directional changes during the VS module will affect selectivity. However, because the encoding time is so short (approximately 20 ms), directional changes are both minor and expected to average out given the broad distribution of vessel orientation in a parenchymal voxel. In this way, as long as there exists some flowing blood with a velocity component aligned with the encoding direction greater than V CUTOFF , VT-VSSL can occur. A more detailed discussion of the directional sensitivity of the VS module is discussed by Frank et al. (20) .
T 1 relaxation complicates the idealized model depicted in Fig. 4 . Spins dephased by VS1 at t = 0 experience longitudinal magnetization recovery. Because velocity selection via VS2 occurs only for the tag but not control, spins from unwanted compartments will partially recover in the control, but dephase in the tag at TO+. Without compensation, these unwanted spins will not subtract completely, and QUIXOTIC loses venous selectivity. To address this effect, we place an inversion pulse at time TO 1 to null recovering blood at TO; consequently, signal from spins in this unwanted population is eliminated in both control and tag at TO, leaving only desired PCV blood on subtraction.
To generate the PCV blood-weighted maps at different echo times, T 2 preparation is integrated into the VS2 pulse train. For the shortest effective echo time (TE eff ), the VS2 module is exactly as pictured in Fig. 2 . For each successive TE eff , an additional pair of adiabatic 180° pulses is added between the flip-up 90° pulse and first VS gradient lobe. In this way, the duration of VS2 will increase by ΔTE eff for each successive TE eff . Importantly, this is done while keeping an identical readout onset time regardless of TE eff . Using T 2 preparation and fixing the readout module timing makes the T 2 encoding flow insensitive; in other words, images at successive TE eff should differ only by T 2 weighting, not by volume of blood delivered during TO (18) .
Signal intensity (SI) in the acquired blood-weighted images can be plotted versus TE eff and fit exponentially on a voxel-by-voxel basis to generate T 2 maps of PCV blood. T 2 values are then calibrated to Y v and Eqs. 1 and 2 can be used compute CMRO 2 and OEF. The following sections explain these steps in greater detail.
T 2 Estimate: Determination of Effective Echo Times (TE eff )
Proper estimates of T 2 from fitting SI versus TE eff data depend on accurate estimates of TE eff at each successive acquisition. Ideally, TE eff is equal to the duration of the T 2 -preparation module, assuming pure T 2 relaxation and very short refocusing pulses. In practice, however, magnetization does not experience pure T 2 decay during the hyperbolic secant refocusing pulses (18) , and further, despite a long repetition time (TR; 4 s), a small amount of residual T 1 contamination is present from spins that have not completely relaxed. To reduce the impact of such biases to the T 2 estimate, we derived a small adjustment to the nominal echo spacing and applied the resulting effective echo spacing, ΔTE eff , for T 2 estimation from the measured data. Specifically, we simulated the pulse sequence using the Bloch equation, assumed T 1 and T 2 decay during the hyperbolic secant refocusing pulses, and estimated the ΔTE eff appropriate for our pulse sequence. The T 1 and T 2 used for the simulation were 1660 and 70 ms, respectively, which are approximate T 1 and T 2 values for deoxygenated blood at 3 T (13,21).
T 2,blood Versus Y Calibration
The relationship between transverse relaxation time of blood and blood oxygen saturation (Y) was first examined in the early 1980s, by Thulborn et al. (22) . In years following, a parametric model based on the Luz-Meiboom model of spin relaxation during twocompartment exchange (in this case, between plasma and the red blood cell) was derived to fit experimental data measuring variations of T 2,blood and blood oxygen saturation. Such work enabled MRI-based measurements of oxygen saturation in vivo (23) . In 1998, Van Zijl et al. proposed a fundamental theory for T 2 -based signal changes in perfused tissue and presented a quantitative model linking T 2 relaxation of blood to physiologic parameters including Y (2, 12) . This expression can be written in terms of T 2, blood , Y, and hematocrit (Hct) in the following form: (7) where A, B, C, D, and E represent lumped biophysical parameters related to susceptibility differences between the red blood cell and plasma, water relaxation rates in the red blood cell and plasma, and the spacing between 180° RF pulses in a CPMG spin-echo module (τ CPMG ).
Fit of available Y versus T 2,blood data at 3 T obtained from in vitro bovine blood (3 T, Carr Purcell Meiboom Gill (CPMG) multiecho T 2 sequence, τ CPMG = 10 ms, courtesy of P. van Zijl and C. Clingman, Johns Hopkins University), yielded values for A, B, C, D, E, that we used in our work. Using these values, Y versus T 2 curves (with Hct as an independent parameter) were generated. Bovine blood has the same properties as human blood in terms of hemoglobin content, erythrocyte size, and diffusional permeability and is expected to have similar MR relaxation properties (12) . It has been successfully used in the past for similar calibration experiments (12, 13, 24) .
Calculation of CMRO 2 From Y v
Once Y v is obtained, CMRO 2 and OEF can be calculated by using Eqs. 1 and 2, with the final hematocrit measurement used to calculate the total hemoglobin concentration: [8] 
MATERIALS AND METHODS
QUIXOTIC was used to evaluate Y v , OEF, and CMRO 2 in healthy volunteers. The protocol was approved by the University's Committee of Using Humans as Experimental Subjects. Ten young (22-32 years) nonsmoking, healthy subjects (six females, four male) were scanned at 3 T (Siemens Tim Trio, Erlangen, Germany) with the following MRI protocol: Either five or six TE eff s (depending on specific absorption rate constraints) were acquired with a ΔTE eff = 18.4 ms.
3.
Pulsed arterial spin label (ASL) CBF imaging: PICORE/Q2tips (25), TI 1 = 700 ms, TI 1 stop time = 1400 ms, TI 2 = 1600 ms, pulsed ASL gap = 10 mm, Tag thickness = 160 mm, TR = 2000 ms, one slice, 60 measurements, acquisition time = 2 min. EPI parameters are as listed for 3). M 0 calibration scan had identical imaging parameters, except ASL-specific pulses were disabled, and only one measurement was acquired.
Double inversion recovery (DIR)
for GM-only images: TI 1 = 3700 ms, TI 2 = 4280 ms, one slice, one measurement, with EPI parameters as listed in 3.
5.
TRUST sagittal sinus blood imaging: tag thickness = 50 mm, gap = 10 mm, TI = 800 ms, TR = 8 s, eight measurements per TE eff were acquired, ΔTE eff = 18.0 ms, one slice. EPI parameters and T 2 preparation are as listed for 2. Hyperbolic secant pulses identical to those in QUIXOTIC were used for TRUST T 2 preparation.
Automatic alignment routines (26) were used to ensure similar slice placement among all subjects. A slightly oblique-axial slice-of-interest was prescribed immediately superior to the corpus callosum for acquisitions two to four and contained a significant fraction of GM. A different oblique-axial slice intersecting the sagittal sinus was positioned for acquisition five (TRUST).
Venular blood-weighted imaging comprised the bulk of the scan session and the imaging time for the full protocol was less than an hour. Data were acquired at six TE eff s if possible, but in four subjects, specific absorption rate constraints imposed a limitation of only five TE eff s. To test the reproducibility, we performed the VT-VSSL experiment twice on two of the volunteers. These volunteers remained in the scanner for an additional 30 min for the second VT-VSSL acquisition. The two VT-VSSL trials were spaced approximately half an hour apart and used identical scan parameters.
After MRI scanning, hematocrit was measured via finger prick blood sample using the Ultracrit device (Separation Technologies, Altamonte Springs, FL). O 2 saturation was measured with a pulse oximeter (8600FO Pulse Oximeter, Magmedix, Fitchburg, MA).
The data from each TE eff acquisition were corrected for bulk motion and then subtracted, control minus tag, in a pairwise fashion. The subtraction series was averaged to produce mean PCV-weighted images. The DIR image was used as a GM mask, within which venular blood SI from cortical GM tissue was measured. PCV blood signal intensities from the entire cortical GM region were plotted versus TE eff to provide whole-slice cortical GM measurements. The plots were then exponentially fit using a Levenberg-Marquardt least squares optimization method to measure the T 2 relaxation parameter for whole-slice cortical GM, and the standard error of the estimated parameter (SEE) assuming a t-distribution was computed.
The TRUST acquisitions were similarly subtracted in a pairwise fraction and averaged to produce maps containing sagittal-sinus only blood at the five TE eff s. The mean SI from the six brightest sagittal sinus voxels blood was plotted versus TE eff and fit to estimate sagittalsinus blood T 2 . The SEE assuming a t-distribution was computed.
T 2 values from both VT-VSSL and TRUST analyses were then calibrated to Y v using curves generated with Eq. 7, incorporating the hematocrit measured from the volunteer. As VT-VSSL data derive mostly from blood in small vessels, the T 2 versus Y calibration was calculated using the microvascular hematocrit (i.e., by multiplying the measured hematocrit by 0.85 to correct for hematocrit differences between small and large vessels; Ref. 27 ). This correction was not needed for the TRUST calibration curves, as the source of venous blood was exclusively from the large sagittal sinus. Y a was taken as the oxygen saturation measured with the pulse oximeter; Eq. 2 was then used to calculate OEF.
To obtain CMRO 2 from Eq. 1, CBF was estimated by ASL MRI, with a VT-VSSL matching slice prescription. The ASL data were similarly analyzed to generate blood flow-weighted images, via subtraction, motion correction, and signal averaging. These images were calibrated to absolute CBF maps by using the local tissue proton density provided by the M 0 scan (28) . GM CBF was estimated from the region segmented by the DIR GM mask. White matter (WM) CBF was estimated from the remaining, nonsegmented brain region. The WM and GM CBF values were used to calculate whole brain CBF, by assuming a whole-brain WM:GM ratio of 0.675:1 (29) . With these additional CBF measurements, and by using hematocrit to estimate [Hb total ], both QUIXOTIC (GM) and TRUST (whole brain) CMRO 2 were, respectively, calculated.
To demonstrate feasibility of using QUIXOTIC to create quantitative Y v , OEF, and CMRO 2 maps, raw data from a representative subject were smoothed with a 10 mm full width at half maximum (FWHM) Gaussian kernel and fit for T 2 , but this time on a voxel-by-voxel basis (as opposed to using a GM mask). Figure 5 shows the mean difference images for the VT-VSSL and TRUST acquisitions at five effective TEs for a representative subject. The signal in the VT-VSSL images is our estimate of the PCV blood, which decays with a T 2 time constant that depends on the blood oxygenation level. Figure 6a and b show the ASL-CBF map and the GM mask, respectively. Figure 6c displays the slice orientation of the preceding acquisitions, overlaid on a high resolution midsagittal section from the MP-RAGE scan. Figure 7 shows the whole-slice cortical-GM SI versus TE eff (QUIXOTIC) and sagittal sinus SI versus TE eff (TRUST) on a semilog scale for all subjects, including the fitted lines for T 2 estimates. All line fits had high R 2 values: ≥0.95 for QUIXOTIC and ≥0.99 for TRUST. To improve the figure readability and highlight the relevant parameter (slope of line fits), the vertical offset of each line in each technique has been normalized. The y-intercept estimates the volume of tagged blood that remains after subtraction within the sagittal sinus and GM voxels for TRUST and QUIXOTIC, respectively, but does not enter the OEF or CMRO 2 estimates. Figure 8 shows calibration curves generated with Eq. 7 for the same subject. Values of A, B, C, D, and E for Eq. 7 were found as 1.09 s −1 , 11.26 s −1 , −7.96 s −1 , 1.08 s −1/2 , and 16.54 s −1/2 , respectively. Two curves are depicted for both microvascular and macrovascular hematocrit, to be used for QUIXOTIC and TRUST analyses, respectively. Lower hematocrit shifts the T 2,blood versus Y curve to the left, resulting in lower estimated oxygen saturations (Y) for a fixed measured T 2,blood value. Figure 9 shows the Y v , OEF, and CMRO 2 maps for the same representative subject, created by applying QUIXOTIC theory on a voxel-by-voxel basis. Y v and OEF is seen to be relatively uniform across the entire brain, while the CMRO 2 map shows substantially higher values in the GM cortex, compared to the interior WM. Table 2 shows the intrascan test-retest data for subjects 1 and 2, including the percent difference in the quantified parameters. The differences were low in both cases, less than 1% and 5% for subjects 1 and 2, respectively.
RESULTS
DISCUSSION
We have introduced a novel MR technique, QUIXOTIC, to quantify regional OEF and regional CMRO 2 and have demonstrated its use in normal volunteers. Our estimates of cortical GM OEF and CMRO 2 fall within the expected physiological range and are comparable with those reported by other MRI and positron emission tomography methods (10, (30) (31) (32) (33) . Some studies that measure OEF specifically report values of 35%, 42.6%, 41%, and 40% (34-37), which are slightly higher than the 26% reported here. WM values were not calculated in this investigation, due to low WM SNR in VT-VSSL maps for several subjects.
QUIXOTIC produces venular blood maps by creating flow-derived signal from within the imaging voxel. In principle, this property allows generation of venular blood maps on a voxel-by-voxel basis. By obtaining maps at several effective echo times (T eff ), it is possible to fit for T 2 and subsequently obtain voxelwise measures of Y v , OEF, and CMRO 2 (as shown in Fig. 9 ). Of note, we assumed T 1 and T 2 values of 1660 and 70 ms, respectively, to estimate ΔTE eff via Bloch simulation. Deviations in these assumed values will result in a small bias in the QUIXOTIC measured T 2 s of venular blood. To examine this effect more closely, we tested: (a) the range of T 1 s from 1560 and 1760 and found a resulting effect of approximately 0.5 ms on estimated T 2 , and (b) the range of T 2 s between 50 and 90 ms, resulting in an effect of approximately 2.5 ms on measured T 2 . Even at the extremes, these small deviations in measured T 2 will result in even smaller deviations on measured Y v , OEF, and CMRO 2 (between 1 and 2%); well within the noise of our measurement.
Outflow Time and Cutoff Velocity (V CUTOFF )
Two key parameters define the nature of the QUIXOTIC signal and directly control its spatial specificity, signal-to-noise ratio (SNR), and maximum SNR: cutoff velocity (V CUTOFF ) and TO. When taken together, V CUTOFF and TO determine the extent of the velocity-selected bolus at imaging time by defining its trailing and leading edge, respectively, and subsequently the venular blood component remaining in the subtracted image.
The TO of the QUIXOTIC experiment determines the SNR and spatial specificity of the subtracted venular blood component. During TO, blood spins accelerate above the V CUTOFF threshold and into receiving venular vasculature within the imaging voxel. Imaging signal is created, and intensity increases as these spins begin to fill the imaging voxel. Neglecting T 1 decay, the final SI is directly proportional to the volume of blood that has accelerated above V CUTOFF during TO, while still remaining within the voxel (hereafter termed as "imaging blood volume"). Realistically, however, T 1 decay will have a competing effect on overall SI; thus in practice, an SNR-optimized TO will consider both imaging blood volume and T 1 decay.
As flowing spins in the velocity-selected bolus disseminate through the tortuous venular microvasculature during TO, they flow deeper into the venous circulation, and the leading edge of the bolus travels further away from capillary sites of gas exchange. As long as these tagged spins do not leave the voxel, oxygen saturation within these pools properly represents oxygen exchange of their capillary sources. Spatial specificity is preserved, and imaging blood volume is exactly the product of venular outflow and TO.
V CUTOFF determines the maximum possible SNR of the venular blood component in the final image, by defining the maximum available vascular volume that can be occupied by the venular bolus. As blood velocity is closely related to vessel caliber, V CUTOFF not only defines the cutoff blood velocity, but also determines how far into the venous vascular tree the trailing edge of imaged bolus is located. A low V CUTOFF means that trailing edge originates closer to the distal end of the capillary bed, while a high V CUTOFF means that the trailing edge originates closer to terminal draining veins. As V CUTOFF increases, the trailing edge moves farther along the venous vascular tree, effectively reducing the remaining vascular voxel volume that can be filled by tagged blood. In this way, V CUTOFF sets a hard limit to the maximum imaging blood volume that can occupy a voxel, with lower V CUTOFF s offering higher SI at the optimal TO. A V CUTOFF just above capillary blood velocities is the ideal choice. A V CUTOFF lower than capillary velocities is undesirable for three reasons: (1) VS theory assumes laminar flow, not capillary plug flow (14) , for proper velocity filtering, (2) as V CUTOFF decreases, the relaxed blood pool available to flow above V CUTOFF will at some point become small, also resulting in SNR reduction, and (3) when large velocity weighting is applied, tissue and CSF water diffusion becomes a contaminating source of signal (14) . Notably, prior VS-ASL studies have indicated that a V CUTOFF ≥ 2 cm/s will result in subtractions free from diffusion contamination (14, 38) .
Based on the above considerations and pilot data (39), we chose V CUTOFF = 2 cm/s and TO = 725 ms. These choices yield sufficient SNR in the final venular blood images for cortical analysis at 3 T and maintain high spatial specificity. As seen in Fig. 5 , venular blood signal appears well-matched to cortical gyri, with minimal blurring, which can be appreciated by comparing the venular blood-weighted images to the CBF and DIR images in Fig. 6 .
In this initial demonstration of QUIXOTIC, we performed limited exploration of the dependence of Y v on TO and V CUTOFF parameters. This required development of the turbo QUIXOTIC variant, which allowed the considerably shorter scan times needed to accommodate a multiparameter exploration. Turbo QUIXOTIC differs from the standard approach by using a turbo spin echo readout to acquire data at multiple effective TEs per scan, instead of only at a single TE eff . Consequently, turbo QUIXOTIC generates all necessary images for T 2 fitting and subsequent analysis in a single scan, thereby reducing the required imaging time by several fold. In this specific implementation, the total acquisition time for a fixed TO and V CUTOFF combination decreased from 25-30 min to 5.5 min. This dramatic reduction in imaging time enabled us to explore several TO and V CUTOFF combinations in a single scan session. We used this approach in three subjects to see how calculated Y v varied across (1) a range of TOs at a fixed V CUTOFF = 2 cm/s, and (2) a range of V CUTOFF s at a fixed TO = 725 ms. Figure 10 shows the calculated Y v across these parameter ranges. The average slope of −0.007 per 100 ms for the Y v versus TO data (Fig.  10a) suggests that the measured Y v is robust to variations in TO; across a range of 400 ms, this translates to a less than 3% variation in Y v . On the other hand, Fig. 10b indicates a more significant dependence of Y v on the V CUTOFF parameter; an average slope of −0.03 per cm/s suggests that as V CUTOFF increases over a range of 4 cm/s, the measured Y v will decrease by 12%. Whether this effect is an artifact of increased diffusion weighting at lower V CUTOFF s, or a consequence of the physiologic properties of the isolated venular pool that survives after velocity encoding, is the topic of detailed future QUIXOTIC studies.
An additional positive consequence of using turbo QUIXOTIC is that R 2 for all T 2 fits was >0.99, with an SEE of roughly 3 ms; this marks a substantial improvement over the standard QUIXOTIC variant. We postulate that this improvement is due the fact that turbo QUIXOTIC is considerably more resistant to both bulk and physiological motion for the following reasons: (1) motion affects all TE eff points equally in turbo QUIXOTIC due to parallel TE eff acquisition, whereas it will affect each TE eff point differently in standard QUIXOTIC (due to serial TE eff acquisition) leading to noiser SI versus TE eff data and (2) total scan time is significantly shorter in turbo QUIXOTIC, resulting in less motion artifact across the experiment. Due to higher quality data and reduced scan time, we expect turbo QUIXOTIC to eventually be the variant of choice for Y v , OEF, and CMRO 2 voxel-by-voxel mapping.
Comparison of QUIXOTIC and TRUST Measurements
Values of OEF and CMRO 2 estimated with QUIXOTIC fall within the physiologic range and are in good agreement with other PET and MR measures in the literature. The key physiologic parameter measured by QUIXOTIC is local venular oxygen saturation Y v , which shows low measurement variability across 10 subjects (coefficient of variation = 0.03 Sources of bias may originate from the QUIXOTIC technique itself. Among these is contamination of the venular-derived VS bolus by arterial blood, which could manifest in at least two different ways. As mentioned in Theory section, initially dephased arterial blood will experience T 1 recovery after VS1. In an effort to prevent this blood from giving rise to signal in the final subtraction, we inserted a single inversion pulse at a time TO 1 , which in theory should null this arterial component. TO 1 is based on an assumed T 1,blood (21) ; if the true T 1,blood differs significantly from this assumed value, the inversion null may not be effective, leading to an arterial contribution in the final subtracted signal. As the T 2 of fully oxygenated arterial blood is greater than 150 ms (as empirically determined by ASL-based experiments using an identical T 2 -preparation module), a small fractional contribution of arterial signal could bias the measured T 2 , and subsequently Y v . To explore this potential contamination source, we implemented and tested a double-inversion approach in QUIXOTIC (data not shown), which dramatically improves nulling robustness and reduces signal across a much wider T 1 range (but imposes an additional specific absorption rate penalty). Comparing the single-and double-inversion variants of QUIXOTIC did not yield a substantial change in measured T 2 , leading us to conclude that arterial contamination by incomplete T 1 nulling is not a dominant source of error.
Another possibility for arterial contamination could be attributed to the nonideal velocity selection profile. While the ideal velocity-selective profile perfectly preserves signal from all spins below V CUTOFF and dephases all spins above V CUTOFF , the actual VS profile follows a sinc envelope as a function of spin velocity (Fig. 2) . Consequently, the final VS bolus will also have a sinc-like shape, including side lobes that extend into the arterial side of the circulation. As TO increases, the VS bolus will move further into the venous circulation, and the side lobes on the arterial side become smaller, resulting in less contamination. This potential contamination source was explored with turbo QUIXOTIC in three subjects, and as previously mentioned, there was little variation in measured Y v across a TO range of 400 ms. These turbo QUIXOTIC data suggest that this source of arterial contamination is not a large source of bias in QUIXOTIC.
A second potential source of bias in measuring Y v with QUIXOTIC is the inevitable diffusion weighting in the experiment. The combination of gradient and RF pulses that allow velocity selection will at the same time lead to (mild) diffusion weighting. As the control image acquisition involves turning off the gradients during VS2, the control image will not be diffusion weighted, while the tag image will be slightly diffusion weighted. The subsequent subtraction map will have some degree of diffusion weighting, thus introducing both tissue and CSF components into the otherwise pure venular blood-weighted images. This problem was explored by Wong and colleagues for VS-ASL (14, 40) . Both studies concluded that diffusion effects were minimal, due to the weak gradients (G), short gradient durations (δ), and large gradient separation (Δ) used in the VS module. In our specific experiments, b value was calculated to be approximately 1 s/mm 2 , leading to less than 0.07% attenuation in tissue (D tissue = 0.0008 mm 2 /s) and less than 0.020% attenuation in CSF (D CSF = 0.0024 mm 2 /s), given CSF and tissue fractions of up to 95% (41) and up to 10% (42), respectively. Given that the subtracted blood-weighted signal is roughly 2% of the original signal, we expect less than 4% error from diffusion effects at TE eff = 0. However, because the T 2 s of CSF and tissue are longer than the T 2 of deoxygenated blood, diffusionbased effects could become more prominent at longer effective echo times. Results from the turbo QUIXOTIC parameter exploration are consistent with this idea. As seen in (Fig. 10b) . Y v (and thus T 2 ) increases with decreasing V CUTOFF . One explanation for this phenomenon is that lower V CUTOFF s result in images containing non-negligible signal from diffusing tissue/CSF water. As water from these sources has a larger T 2 than venular blood water, the measured T 2 (and subsequent Y v ) could be biased upward. In this limited turbo QUIXOTIC dataset, it is also interesting to note that as V CUTOFF increases (and diffusion effects An important practical difference between TRUST and QUIXOTIC is SNR. SNR is directly related to the imaging blood volume, which is represented by the vertical intercepts in Fig.  7a . Because of the high fractional blood volume in the sagittal sinus (approximately 1), the imaging blood volume is between one and two orders of magnitude greater in TRUST, compared to QUIXOTIC. In this way, TRUST has a major SNR advantage, affording shorter imaging times and higher precision fits.
While beyond the scope of this article, a brief comment can be made on the feasibility of using QUIXOTIC (and more specifically the turbo QUIXOTIC variant) in functional MRI. The primary advantage offered by QUIXOTIC is the ability to generate a OEF and CMRO 2 map every two TR (analogous to how CBF maps are generated in ASL-fMRI). While the TR used in these studies was 4 s, shorter TRs (on the order of 2 ms) are possible, with similar temporal SNR. In this way, similar to functional ASL-MRI, we anticipate useful application of QUIXOTIC in block design and event-related fMRI experiments. One potential confounder is the increase of local CBF during activation; however, we do not anticipate this to cause a large error. While the trailing edge of the VT-VSSL bolus will be closer to the capillary bed during activation, venular blood will still be considered and oxygenation properly represented (substantial venular oxygenation heterogeneity, however, could complicate this picture). Idealized cartoon of venular blood signal targeting in QUIXOTIC approach, as told via spin configuration throughout the experiment. Relaxed spins are denoted by upright arrows; dephased spins by hollow circles. Dotted vertical lines correspond to 1 cm/s blood velocity (i.e., the cutoff velocity in b and d).
CONCLUSIONS
FIG. 5.
TRUST (top) and QUIXOTIC (bottom) mean difference images from representative subject. Mean difference images are an average of many control-tag subtractions and reflect sagittalsinus blood weighting in TRUST and venular blood weighting in QUIXOTIC.
FIG. 6.
Representative CBF image (top-left), DIR image (bottom-left), and anatomical MP-RAGE with prescribed slice overlay (right). QUIXOTIC, ASL, and DIR sequences acquired data in this slice orientation.
FIG. 7.
TRUST and QUIXOTIC log(SI) versus effective echo time curves and corresponding T 2 fits for all 10 subjects. Vertical offset of the fit lines have been normalized for minimum variance within TRUST and QUIXOTIC datasets. Solid blue and red lines represent mean T 2 fit curves for all 10 subjects, for TRUST and QUIXOTIC, respectively. The vertical intercept estimates the imaging blood volume within sagittal sinus and GM voxels for TRUST and QUIXOTIC, respectively. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
FIG. 8.
Representative T 2 versus Y calibration curves for the representative subject, generated with microvascular (red) and macrovascular (blue) hematocrit, using Eq. 7. These curves are used to calibrate T 2 to blood oxygen saturation for the QUIXOTIC and TRUST experiments.
[Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
FIG. 9.
Quantitative Y v (left), OEF (middle), and CMRO 2 (right) maps for representative subject, created by applying QUIXOTIC theory on a voxel-by-voxel basis.
FIG. 10.
Y v versus TO (a) and Y v versus V CUTOFF (b) for the parameter exploration data acquired with turbo QUIXOTIC in three reimaged subjects. Error bars represent the SEE. Table 1 Summary of QUIXOTIC and TRUST Data for all 10 Volunteers 
